Fair Value Calculator Fair Value Calculator
EN DE

0244 (0244) Fair Value & Analysis

Consumer Cyclical · Market cap HK$388M

0 0244 0244 · HK
PriceHK$0.2950
Fair ValueHK$0.0300
Upside-89.8%
Quality41/100
Evidence: Low Range HK$0.0300 – HK$0.0400

Fair value as of: Jul 1, 2026

From 3 valuation models · updated today

Share price +5.4% over the past month.

Price vs Fair Value (12 months)

HK$0.4250 HK$0.2310 Fair Value HK$0.0300 Jun 2025 Jun 2026

12‑month range HK$0.2310 – HK$0.4250 · fair‑value band HK$0.0300 – HK$0.0400 · the HK$0.2950 price screens above the HK$0.0300 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0244 (0244) currently trades at HK$0.2950, while our model-based Fair Value estimate is HK$0.0300 — implying the stock looks roughly 89.8% overvalued today. We read business quality at 41/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0244 generated revenue of HK$134M at a net margin of -47.8%. Revenue grew 5.5% year over year. Net debt stands at HK$174M. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$134M
Revenue growth (YoY) +5.5%
Net margin -47.8%
Return on equity -102%
Free cash flow −HK$33.8M FY2026
Operating margin -27.7%
More key figures
EPS (TTM) HK$-0.0200
Net debt HK$174M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

0244 reported revenue of HK$134M in FY2026 versus HK$168M in FY2022, a compound −5.5%/yr. Reported net income was −HK$64.1M in FY2026.

Revenue −5.5%/yr
FY22 HK$168M
FY23 HK$147M
FY24 HK$146M
FY25 HK$131M
FY26 HK$134M
Net income
FY22 −HK$91.1M
FY23 −HK$62.3M
FY24 −HK$50.5M
FY25 −HK$40.1M
FY26 −HK$64.1M

Is 0244 fairly valued? → Check now

Similar stocks

6 more Department Stores stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock Price Fair Value vs Fair Value
Aeon Co AONNY $8.02 $4.68 -42%
Falabella S.A FALABELLA 6,052 CLP 9,834 CLP +62%
SM Investments Corporation SVTMF $10.15 $21.80 +115%
Ryohin Keikaku Co RYKKY $11.15 $6.53 -41%
Shoprite Holdings SRGHY $18.32 $18.67 +2%
Marks and Spencer Group MAKSY $9.33 $12.57 +35%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0244 (0244) undervalued?
As of Jul 1, 2026, our model estimates a fair value of HK$0.0300 versus a price of HK$0.2950 — about −90% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0244?
Our model-based fair value for 0244 is HK$0.0300 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.2950.
What is the quality score of 0244?
0244 has a Quality Score of 41/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0244 (0244)?
0244 reported trailing-twelve-month revenue of about HK$134M (latest available figure, as of Jul 1, 2026).
What is the net profit margin of 0244?
The net profit margin of 0244 is about -47.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.